Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Wyeth: PharmaVitae Profile' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Wyeth: PharmaVitae Profile PharmaVitae Profile |
March 2009 | £3010 | 100 % |
|
Wyeth IMS Company Profile |
November 2008 | £510 | 68 % |
|
Wyeth PharmaVitae Profile |
July 2008 | £3010 | 50 % |
|
Wyeth - SWOT Analysis |
December 2008 | £66 | 35 % |
|
Wyeth - OTC Healthcare World |
January 2008 | £195 | 29 % |
|
Wyeth - OTC Healthcare - World |
December 2008 | £245 | 28 % |
|
Progenics Pharmaceuticals, Inc. - SWOT Analysis |
September 2008 | £66 | 24.5 % |
|
The Top 50 Pharmaceutical Manufacturing Companies In Ireland |
September 2005 | £285 | 24.5 % |
|
Neurodegenerative Market Forecast to 2013 |
February 2009 | £6100 | 18 % |
|
Wyeth Partnering Guide 2008 |
July 2008 | £195 | 17.15 % |
|
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market |
April 2008 | £8000 | 16.5 % |
|
Global Vaccine Market Outlook (2007-2010) |
June 2007 | £975 | 16.5 % |
|
Takeda Pipeline, Products,Performance,Potential |
October 2008 | £595 | 14.5 % |
|
Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape |
August 2008 | £3800 | 14.35 % |
|
Mergers and Acquisitions in the Pharmaceuticals Sector, 2009 Critical success factors for competing in a consolidating market |
April 2009 | £1955 | 13.65 % |
|
Eye Care in the United Kingdom |
August 2006 | £450 | 13.3 % |
|
Wound Treatments in the United Kingdom |
August 2006 | £450 | 13.3 % |
|
Analgesics in the United Kingdom |
August 2006 | £450 | 12.95 % |
|
Medicated Skin Care in the United Kingdom |
August 2006 | £450 | 12.6 % |
|
NRT Smoking Cessation Aids in the United Kingdom |
August 2006 | £450 | 12.6 % |
|
Eye Care in United States |
May 2006 | £450 | 12.6 % |
|
Vitamins and Dietary Supplements in the United Kingdom |
August 2006 | £450 | 12.6 % |
|
The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe (2nd ed.) |
April 2004 | £595 | 12.5 % |
|
NRT Smoking Cessation Aids in United States |
May 2006 | £450 | 12.25 % |
|
The Top 40 Manufacturers Of Orthopaedic Implants In Europe |
May 2005 | £240 | 12 % |
|
The Top 100 Contract Research Organisations In Europe |
April 2004 | £595 | 12 % |
|
The Top 40 Manufacturers Of Wound Care Products In Europe |
June 2009 | £240 | 12 % |
|
Medicated Skin Care in United States |
May 2006 | £450 | 11.9 % |
|
Digestive Remedies in United States |
May 2006 | £450 | 11.9 % |
|
Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom |
August 2006 | £450 | 11.9 % |
|
Vitamins And Dietary Supplements in United States |
May 2006 | £450 | 11.9 % |
|
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe |
June 2009 | £275 | 11.5 % |
|
CNS Market Trends, 2007 to 2010 Key Market Forecasts and Growth Opportunities |
June 2007 | £995 | 11.2 % |
|
Cough, Cold And Allergy (Hay Fever) Remedies in United States |
May 2006 | £450 | 11.2 % |
|
The Top 100 Point-Of-Care Manufacturing Companies Worldwide Second Edition |
May 2009 | £595 | 11 % |
|
Pharmaceutical Market Trends, 2008 - 2012 Key market forecasts and growth opportunities (3rd Edition) |
November 2008 | £1350 | 10.85 % |
|
The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide |
May 2005 | £245 | 10.5 % |
|
The Top 50 Neurodevice Companies Worldwide |
June 2009 | £300 | 10.5 % |
|
Pharmaceutical Product Approval Trends, 2007 Key Market Benchmarks And Strategic Insights |
December 2007 | £995 | 9.1 % |
|
Medicated Skin Care in Venezuela |
February 2008 | £450 | 9.1 % |
|
Merck KGaA - OTC Healthcare - World |
January 2008 | £195 | 8.75 % |
|
Wound Treatments in Japan |
September 2007 | £450 | 8.75 % |
|
Eye Care in Brazil |
August 2007 | £450 | 8.4 % |
|
Wound Treatments in China |
July 2008 | £450 | 8.05 % |
|
Merck & Co. Inc: PharmaVitae Profile |
March 2009 | £3010 | 8.05 % |
|
NRT Smoking Cessation Aids in China |
July 2008 | £450 | 8.05 % |
|
Medicated Skin Care in China |
July 2008 | £450 | 8.05 % |
|
Eye Care in China |
July 2008 | £450 | 8.05 % |
|
Vitamins and Dietary Supplements in China |
July 2008 | £450 | 7.7 % |
|
Analyzing the Nutraceuticals Market in the UK |
January 2009 | £575 | 7.7 % |
|
Pipeline And Commercial Insight Pediatric And Adolescent Vaccines |
July 2007 | £8000 | 7.35 % |
|
Cough, Cold and Allergy (Hay Fever) Remedies in Japan |
September 2007 | £450 | 7 % |
|
Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong |
October 2007 | £450 | 6.65 % |
|
Bigpharma Dealmaking Handbook Companies & Contacts |
September 2008 | £1195 | 6.65 % |
|
Cough, Cold and Allergy (Hay Fever) Remedies in Mexico |
February 2008 | £450 | 6.65 % |
|
Bigpharma Dealmaking and Agreements Handbook 2007 Companies, Contacts & Partnering Agreements |
September 2007 | £1195 | 6.3 % |
|
Commercial Insight: Antihormonal Therapy Cancer Brands Careful Lifecycle Management Needed to Preserve Brand Dominance |
August 2008 | £7600 | 6.3 % |
|
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry |
April 2009 | £6000 | 5.95 % |
|
U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products |
March 2006 | £1830 | 5.6 % |
|
Partnering with Biopharma The definitive guide to bigpharma partnering interests, contacts & agreements |
July 2008 | £1495 | 5.6 % |
|
Innovations and Trends in Clinical Trials Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology |
March 2007 | £1375 | 5.25 % |
|
Fastest Growing Biotechnology Companies, The Growth Strategies, Comparative Analyses and Company Profiles |
March 2008 | £1995 | 5.25 % |
|
Top 7 Cancer Indications Therapeutic & Competitive Insights |
January 2007 | £5960 | 4.9 % |
|
Indian Pharmaceutical Industry, The: |
March 2005 | £3335 | 4.9 % |
|
Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking |
April 2009 | £1670 | 4.55 % |
|
Pipeline Insight: Bipolar Disorder New treatments for bipolar depression set to drive near-term growth |
September 2006 | £6495 | 4.55 % |
|
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 |
August 2008 | £1499 | 4.55 % |
|
Global Diabetes Market; The Therapeutics, Diagnostics and Complications |
August 2006 | £1525 | 4.2 % |
|
United States Dental Devices Medical Equipment Industry Report Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Dental Equipment, Dental Supplies, Orthodontic Products, Dental X-Ray Equipment, Devices and Supplies |
April 2008 | £1830 | 4.2 % |
|
CNS Drug Discoveries What the Future Holds |
November 2006 | £1995 | 4.2 % |
|
Sleep Disorders Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking |
March 2009 | £2075 | 3.85 % |
|
Commercial and Pipeline Insight Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead |
July 2008 | £7700 | 3.85 % |
|
Pipeline/Commercial Insight: Supportive Care in Oncology Significant growth opportunities exist in new supportive care indications |
June 2007 | £7600 | 3.85 % |
|
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies More drugs on the market, more targets in the pipeline |
October 2006 | £8000 | 3.85 % |
|
Commercial and Pipeline Insight Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead |
July 2008 | £7700 | 3.85 % |
|
Clinical Trials Market 2006, The |
February 2006 | £1499 | 3.85 % |
|
Stakeholder Insight: Chronic Leukemias Is there room left for improvement? |
November 2008 | £8000 | 3.5 % |
|
Pipeline Insight: Schizophrenia |
July 2006 | £6330 | 3.5 % |
|
Therapeutic Monoclonal Antibodies Report 2008-2023 |
July 2008 | £1499 | 3.5 % |
|
Pipeline Insight: Anxiety Disorders A decade of declining revenues |
March 2006 | £6495 | 3.15 % |
|
The Vaccines 2008 World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry |
April 2008 | £2500 | 3.15 % |
|
Monoclonal Antibodies in Cancer Therapy 2009-2024 |
May 2009 | £1499 | 3.15 % |
|
Immunogenicity to Biologics Implications Of Reactions Against Biotech Drugs |
November 2007 | £1450 | 2.8 % |
|
World Gastrointestinal Disorders Market 2008-2023 |
October 2008 | £1499 | 2.8 % |
|
Stakeholder Insight: Psoriasis Biologics are yet to make topical treatments obsolete |
March 2009 | £8000 | 2.8 % |
|
Top 10 Biotech Companies Market Outlook, 2008-2023 |
December 2008 | £1499 | 2.8 % |
|
China Pharma Outsourcing Market By 2015 |
January 2009 | £1065 | 2.8 % |
|
Vaccines: The World Market |
February 2007 | £2435 | 2.8 % |
|
Vaccines The World Market |
February 2007 | £2435 | 2.8 % |
|
Inflammatory Bowel Diseases World Market Report 2009-2024 |
February 2009 | £1499 | 2.45 % |
|
Launch Strategies - Analyzing Market Trends and Regulatory Impacts |
August 2007 | £8010 | 2.45 % |
|
Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success Healthcare |
March 2009 | £2000 | 2.45 % |
|
Pipeline Insight: Molecular Targeted Cancer Therapies More pipeline activity, less product differentiation |
November 2008 | £8000 | 2.1 % |
|
Pipeline and Commercial Insight: Anxiety Disorders Viable indication for antipsychotics companies |
November 2008 | £8000 | 2.1 % |
|
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008 |
May 2007 | £260 | 1.75 % |
|
Companion Biomarkers in Drug Development |
April 2009 | £2075 | 1.75 % |
|
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009 |
June 2008 | £260 | 1.75 % |
|
The Executive Guide to Molecular Imaging |
July 2007 | £595 | 1.05 % |
